Research and Markets: 'Exelixis Inc: Premium Company Profile' - Out Now

Business Wire, June 9, 2008

DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c94179) has announced the addition of "Exelixis Inc: Premium Company Profile" to their offering.

Introduction

- Exelixis is a development-stage biotechnology company dedicated to the discovery and development of small molecule therapeutics for the treatment of cancer and other serious diseases. The company has a fully integrated drug discovery platform to fuel the growth of its development pipeline, which is primarily focused on cancer.

Scope

- Contains corporate strategy, value chain presence and SWOT Analysis Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

- Exelixis is experienced in discovering and developing therapeutics for cancer and renal diseases. The company has in-house and collaborative pipeline products and currently has no marketed products. The company derives its revenues from contract, licensing and collaboration. During 2002-2006, the company's total revenues grew at a CAGR of 22% from $44 million in 2002 to $99 million in 2006. During the period 2006-2010, licensing, collaboration and other revenues are forecasted to grow from $99 million to $301 million. Licensing, collaboration and others would remain to be the sole revenue contributor as the company does not have any launch product or expect to launch over the period 2006-2010.

Reasons to Purchase

- Access all the important information and analysis on the company in a single report Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain Gain access to company's adjusted five year financial data along with key ratios and market capitalization

CONTENTS:

Overview

Catalyst

Summary

Company Structure

Company Overview and Key Facts

Business Description

History

Locations and Subsidiaries

Company Financials

Stock Market Performance

P&L

Balance Sheet

Cash Flow

Business Segment Performance

Products & Services

Pipeline Products

AC Forecast Product Sales

Competitors and Strategic Business Relationships

Key Competitors

Key Suppliers

Key Clients

Shareholding Structure

Strategy

Company View

Corporate Strategy

SWOT Analysis

Overview

Strengths

Weaknesses

Opportunities

Threats

Value Chain Analysis

Discovery and Product Development

Scorecard

Overview

Scorecard Analysis

Key Employees

Key Employee Biographies

Financial and Operational Overview

Financial and Operational Overview

APPENDIX

Ask the analyst

Our consulting

Disclaimer

**TABLES AND FIGURES ALSO INCLUDED**

For more information visit http://www.researchandmarkets.com/reports/c94179

Source: Datamonitor